Drugs / diphtheria, tetanus, and acellular pertussis vaccine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT01250756 | Nov 2010 → Mar 2012 | — | Pfizer | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | diphtheria, tetanus, and acellular pertussis vaccine | “diphtheria, tetanus, and acellular pertussis vaccine (DTaP)” NCT01250756 ↗ |
| Known as | DTaP | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01250756 ↗ |
| Modality | Vaccine | “diphtheria, tetanus, and accelular pertussis vaccine (DTaP)” NCT01250756 ↗ |